Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018144827) USE OF GABOXADOL IN THE TREATMENT OF TINNITUS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/144827 International Application No.: PCT/US2018/016602
Publication Date: 09.08.2018 International Filing Date: 02.02.2018
IPC:
A61K 31/437 (2006.01) ,A61K 31/424 (2006.01) ,A61P 25/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
4353
ortho- or peri-condensed with heterocyclic ring systems
437
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
42
Oxazoles
424
condensed with heterocyclic ring systems, e.g. clavulanic acid
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
Applicants:
OVID THERAPEUTICS INC. [US/US]; 1460 Broadway New York, New York 10036, US
Inventors:
DURING, Matthew; US
Agent:
STEEN, Jeffrey S.; US
CARTER, David M.; US
DELUCA, Peter; US
FARRELL, Raymond E.; US
BREW, Michael R.; US
ROSSELLI, Thomas M.; US
Priority Data:
62/454,28003.02.2017US
62/530,52810.07.2017US
62/536,66925.07.2017US
Title (EN) USE OF GABOXADOL IN THE TREATMENT OF TINNITUS
(FR) UTILISATION DE GABOXADOL DANS LE TRAITEMENT DES ACOUPHÈNES
Abstract:
(EN) Methods of treating tinnitus with gaboxadol or a pharmaceutically acceptable salt thereof are provided. Also provided are therapeutic compositions that may be used to improve one or more symptoms of tinnitus. Methods of treating acute sensorineural hearing loss or Meniere's disease with gaboxadol or a pharmaceutically acceptable salt thereof are provided. Also provided are therapeutic compositions that may be used to improve one or more symptoms of acute sensorineural hearing loss or Meniere's disease.
(FR) L'invention concerne des procédés de traitement des acouphènes avec du gaboxadol ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne également des compositions thérapeutiques qui peuvent être utilisées pour améliorer un ou plusieurs symptômes de l'acouphène. L'invention concerne également des procédés de traitement de la surdité neurosensorielle aiguë ou de la maladie de Menière avec du gaboxadol ou un sel pharmaceutiquement acceptable de celui-ci. L'invention concerne en outre des compositions thérapeutiques qui peuvent être utilisées pour améliorer un ou plusieurs symptômes de la surdité neurosensorielle aiguë ou de la maladie de Ménière.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)